IBM is getting in on the $1,000 genome race — and plan to bring that cost even lower, to $100. The company's approach is based on what it calls "DNA transistor," reports the New York Times.
Already have a GenomeWeb or 360Dx account?Login Now.
Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.
The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.
Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.
In Nature this week: ash dieback disease fungal genome, and more.